SCHEMBL9965896

SCHEMBL9965896

c1cnn(C[C@@H]2[C@@H]3CNC[C@@H]32)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9965916 1.00
SCHEMBL9965873 0.76 HRH3 (0.31)
SCHEMBL9933920 0.72 GAA (0.33)
SCHEMBL9933926 0.72 GAA (0.33)
SCHEMBL9965875 0.70
Hydrochloric Acid SCHEMBL31114436 0.69 SLC6A4 (0.44)
SCHEMBL9965871 0.68 CYP19A1 (0.34)
SCHEMBL9965894 0.68 GAA (0.35)
SCHEMBL9965874 0.68 CYP19A1 (0.34)
SCHEMBL4312859 0.65 BRD4 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470021-B1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2014-10-22 EP disclosed
US-8354403-B2 Pyrrolidine derived beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-01-15 US disclosed
US-20120157432-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME, CORP. (US) 2012-06-21 US disclosed
WO-2011025690-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2011-03-03 WO disclosed